<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356679</url>
  </required_header>
  <id_info>
    <org_study_id>EUPASIDIN-S_P4</org_study_id>
    <nct_id>NCT02356679</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients</brief_title>
  <official_title>A Phase 4, Multicenter, Randomized, Open, Active Drug Comparative Trial to Evaluated the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chong Kun Dang Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chong Kun Dang Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in
      Gastritis Patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cure rate of erosion</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement rate of erosion</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement rate of erythema</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement rate of hemorrhage</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement rate of edema</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement rate of self symptoms</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Acute Gastritis</condition>
  <condition>Chronic Gastritis</condition>
  <arm_group>
    <arm_group_label>Eupasidin-s tab.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>three times per day, 1 tab for each time, PO, during 2weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stillen tab.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>three times per day, 1 tab for each time, PO, during 2weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eupasidin-s Tab</intervention_name>
    <description>three times per day, 1 tab for each time, PO, during 2weeks</description>
    <arm_group_label>Eupasidin-s tab.</arm_group_label>
    <other_name>Artemisia herb isopropanol soft ext. 60mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stillen Tab.</intervention_name>
    <description>three times per day, 1 tab for each time, PO, during 2weeks</description>
    <arm_group_label>Stillen tab.</arm_group_label>
    <other_name>Artemisia asiatica 95% ethanol ext. 60mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age is 19 years old and over, men or women

          2. Patients diagnosed with acute or chronic gastritis by gastroscopy and need a treatment
             for gastritis symptoms

          3. Patients with one or more erosions found by gastroscopy

          4. Patients who voluntarily signed written informed consent may participate in the study

        Exclusion Criteria:

          1. Patients with peptic ulcer and gastroesophageal reflux disease

          2. Patients with Gastrointestinal malignant tumor or surgery related to stomach resection

          3. Patients with thromboembolism and coagulation disorder

          4. Patients with significant cardiovascular, pulmonary, heptic, renal primary disease

          5. Patients with abnormal laboratory result at screening

               -  Aspartate aminotransferase(AST), Alanine aminotransferase(ALT), Creatinine &gt;
                  upper limit of normal range x 2

               -  White blood cell(WBC) &lt; 4,000/mm3

               -  Platelet &lt; 50,000/mm3

          6. Patients administered with H2 receptor antagonists, proton pump inhibitors, muscarine
             receptor antagonists, other gastiritis treatment drug, protective factor builder,
             non-steroid anti-inflammatory drugs prior to study in 2 weeks

          7. History of allergic reaction to the investigational product

          8. Women either pregnant, breast feeding or possible to pregnant without contraceptive
             method

          9. Use of other investigational drugs within 3 months prior to the study

         10. Patients that investigators consider ineligible for this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangyong Seol, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University Busanpaik Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University Busanpaik hospital</name>
      <address>
        <city>Busan</city>
        <state>Busangjin</state>
        <zip>614-735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <state>Deokjin-gu</state>
        <zip>561-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Guangju</city>
        <state>Dong-gu</state>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Ilsan-ro</state>
        <zip>220-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <state>Jung-gu</state>
        <zip>301-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University School of Medicine &amp; Hospital</name>
      <address>
        <city>Iksan</city>
        <state>Muwang-ro</state>
        <zip>570-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <state>Nam-gu</state>
        <zip>705-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <state>Seo-gu</state>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <state>Seo-gu</state>
        <zip>602-812</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Seongdong-gu</state>
        <zip>133-792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2014</study_first_submitted>
  <study_first_submitted_qc>February 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <last_update_submitted>August 21, 2015</last_update_submitted>
  <last_update_submitted_qc>August 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

